TNF and uveitis: All four TNF-α antagonists have been proven to be equally effective in controlling the spinal manifestations of AS and uveitis; however, infliximab and adalimumab have been shown to be slightly more effective for the treatment of extra-spinal features of the disease including acute uveitis.